{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:17:47Z","timestamp":1761513467163},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T00:00:00Z","timestamp":1400803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11033-014-3408-y","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T09:59:00Z","timestamp":1400752740000},"page":"5367-5374","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves\u2019 disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Romina","family":"Dastmalchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Farazmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sina","family":"Noshad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Mozafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Esteghamati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliakbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,23]]},"reference":[{"key":"3408_CR1","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","volume":"358","author":"GA Brent","year":"2008","unstructured":"Brent GA (2008) Clinical practice. Graves\u2019 disease. N Engl J Med 358:2594\u20132605. doi: 10.1056\/NEJMcp0801880","journal-title":"N Engl J Med"},{"key":"3408_CR2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","volume":"24","author":"BS Prabhakar","year":"2003","unstructured":"Prabhakar BS, Bahn RS, Smith TJ (2003) Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy. Endocr Rev 24:802\u2013835","journal-title":"Endocr Rev"},{"key":"3408_CR3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2741\/4141","volume":"18","author":"H Li","year":"2013","unstructured":"Li H, Wang T (2013) The autoimmunity in Graves\u2019s disease. Front Biosci 18:782\u2013787","journal-title":"Front Biosci"},{"key":"3408_CR4","doi-asserted-by":"crossref","first-page":"J307","DOI":"10.1016\/j.jaut.2009.11.019","volume":"34","author":"K Hemminki","year":"2010","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K (2010) The epidemiology of Graves\u2019 disease: evidence of a genetic and an environmental contribution. J Autoimmun 34:J307\u2013J313. doi: 10.1016\/j.jaut.2009.11.019","journal-title":"J Autoimmun"},{"key":"3408_CR5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/thy.2007.0153","volume":"17","author":"EM Jacobson","year":"2007","unstructured":"Jacobson EM, Tomer Y (2007) The genetic basis of thyroid autoimmunity. Thyroid 17:949\u2013961. doi: 10.1089\/thy.2007.0153","journal-title":"Thyroid"},{"key":"3408_CR6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08916930310001603037","volume":"36","author":"Y Ban","year":"2003","unstructured":"Ban Y, Tomer Y (2003) The contribution of immune regulatory and thyroid specific genes to the etiology of Graves\u2019 and Hashimoto\u2019s diseases. Autoimmunity 36:367\u2013379","journal-title":"Autoimmunity"},{"key":"3408_CR7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.2010.1644","volume":"20","author":"Y Tomer","year":"2010","unstructured":"Tomer Y (2010) Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20:715\u2013725. doi: 10.1089\/thy.2010.1644","journal-title":"Thyroid"},{"key":"3408_CR8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/er.2002-0030","volume":"24","author":"Y Tomer","year":"2003","unstructured":"Tomer Y, Davies TF (2003) Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24:694\u2013717","journal-title":"Endocr Rev"},{"key":"3408_CR9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-065X.2006.00459.x","volume":"214","author":"SI Khakoo","year":"2006","unstructured":"Khakoo SI, Carrington M (2006) KIR and disease: a model system or system of models? Immunol Rev 214:186\u2013201. doi: 10.1111\/j.1600-065X.2006.00459.x","journal-title":"Immunol Rev"},{"key":"3408_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","volume":"149","author":"RJ Boyton","year":"2007","unstructured":"Boyton RJ, Altmann DM (2007) Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 149:1\u20138. doi: 10.1111\/j.1365-2249.2007.03424.x","journal-title":"Clin Exp Immunol"},{"key":"3408_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2567.2010.03337.x","volume":"131","author":"J Bergen van","year":"2010","unstructured":"van Bergen J, Koning F (2010) The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology 131:301\u2013309. doi: 10.1111\/j.1365-2567.2010.03337.x","journal-title":"Immunology"},{"key":"3408_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","volume":"5","author":"P Parham","year":"2005","unstructured":"Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201\u2013214. doi: 10.1038\/nri1570","journal-title":"Nat Rev Immunol"},{"key":"3408_CR13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1744-313X.2011.01024.x","volume":"38","author":"N Tajik","year":"2011","unstructured":"Tajik N, Shahsavar F, Poormoghim H, Radjabzadeh MF, Mousavi T, Jalali A (2011) KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population. Int J Immunogenet 38:403\u2013409. doi: 10.1111\/j.1744-313X.2011.01024.x","journal-title":"Int J Immunogenet"},{"key":"3408_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0961203310385266","volume":"20","author":"LS Pedroza","year":"2011","unstructured":"Pedroza LS, Sauma MF, Vasconcelos JM, Takeshita LY, Ribeiro-Rodrigues EM, Sastre D, Barbosa CM, Chies JA, Veit TD, Lima CP, Oliveira LF, Henderson BL, Castro AP, Maia MH, Barbosa FB, Santos SE, Guerreiro JF, Sena L, Santos EJ (2011) Systemic lupus erythematosus: association with KIR and SLC11A1 polymorphisms, ethnic predisposition and influence in clinical manifestations at onset revealed by ancestry genetic markers in an urban Brazilian population. Lupus 20:265\u2013273. doi: 10.1177\/0961203310385266","journal-title":"Lupus"},{"key":"3408_CR15","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.molimm.2011.05.018","volume":"48","author":"JA Garcia-Leon","year":"2011","unstructured":"Garcia-Leon JA, Pinto-Medel MJ, Garcia-Trujillo L, Lopez-Gomez C, Oliver-Martos B, Prat-Arrojo I, Marin-Banasco C, Suardiaz-Garcia M, Maldonado-Sanchez R, Fernandez-Fernandez O, Leyva-Fernandez L (2011) Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients. Mol Immunol 48:1896\u20131902. doi: 10.1016\/j.molimm.2011.05.018","journal-title":"Mol Immunol"},{"key":"3408_CR16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.humimm.2004.05.008","volume":"65","author":"W Luszczek","year":"2004","unstructured":"Luszczek W, Manczak M, Cislo M, Nockowski P, Wisniewski A, Jasek M, Kusnierczyk P (2004) Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 65:758\u2013766. doi: 10.1016\/j.humimm.2004.05.008","journal-title":"Hum Immunol"},{"key":"3408_CR17","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.4049\/jimmunol.169.6.2818","volume":"169","author":"MP Martin","year":"2002","unstructured":"Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, Wilson MJ, Trowsdale J, Gladman D, Carrington M (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169:2818\u20132822","journal-title":"J Immunol"},{"key":"3408_CR18","author":"E Ashouri","year":"2013","unstructured":"Ashouri E, Dabbaghmanesh MH, Ranjbar Omrani G (2013) Presence of more activating KIR genes is associated with Hashimoto\u2019s thyroiditis. Endocrine. doi: 10.1007\/s12020-013-0080-2","journal-title":"Endocrine"},{"key":"3408_CR19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1399-0039.2007.00923.x","volume":"70","author":"C Vilches","year":"2007","unstructured":"Vilches C, Castano J, Gomez-Lozano N, Estefania E (2007) Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. Tissue Antigens 70:415\u2013422. doi: 10.1111\/j.1399-0039.2007.00923.x","journal-title":"Tissue Antigens"},{"key":"3408_CR20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-0039.1991.tb01872.x","volume":"37","author":"O Olerup","year":"1991","unstructured":"Olerup O, Zetterquist H (1991) HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens 37:197\u2013204","journal-title":"Tissue Antigens"},{"key":"3408_CR21","doi-asserted-by":"crossref","first-page":"e15115","DOI":"10.1371\/journal.pone.0015115","volume":"5","author":"CW Pyo","year":"2010","unstructured":"Pyo CW, Guethlein LA, Vu Q, Wang R, Abi-Rached L, Norman PJ, Marsh SG, Miller JS, Parham P, Geraghty DE (2010) Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS ONE 5:e15115. doi: 10.1371\/journal.pone.0015115","journal-title":"PLoS ONE"},{"key":"3408_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/378245a0","volume":"378","author":"JE Gumperz","year":"1995","unstructured":"Gumperz JE, Parham P (1995) The enigma of the natural killer cell. Nature 378:245\u2013248. doi: 10.1038\/378245a0","journal-title":"Nature"},{"key":"3408_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930290005864","volume":"35","author":"AG Baxter","year":"2002","unstructured":"Baxter AG, Smyth MJ (2002) The role of NK cells in autoimmune disease. Autoimmunity 35:1\u201314","journal-title":"Autoimmunity"},{"key":"3408_CR24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni1114","volume":"5","author":"DH Raulet","year":"2004","unstructured":"Raulet DH (2004) Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5:996\u20131002. doi: 10.1038\/ni1114","journal-title":"Nat Immunol"},{"key":"3408_CR25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.leu.2404279","volume":"20","author":"S Verheyden","year":"2006","unstructured":"Verheyden S, Demanet C (2006) Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. Leukemia 20:1437\u20131438. doi: 10.1038\/sj.leu.2404279","journal-title":"Leukemia"},{"key":"3408_CR26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00262-004-0575-z","volume":"54","author":"E Naumova","year":"2005","unstructured":"Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M (2005) Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother 54:172\u2013178. doi: 10.1007\/s00262-004-0575-z","journal-title":"Cancer Immunol Immunother"},{"key":"3408_CR27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","volume":"122","author":"E Poszepczynska-Guigne","year":"2004","unstructured":"Poszepczynska-Guigne E, Schiavon V, D\u2019Incan M, Echchakir H, Musette P, Ortonne N, Boumsell L, Moretta A, Bensussan A, Bagot M (2004) CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol 122:820\u2013823. doi: 10.1111\/j.0022-202X.2004.22326.x","journal-title":"J Invest Dermatol"},{"key":"3408_CR28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.20042158","volume":"201","author":"M Carrington","year":"2005","unstructured":"Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201:1069\u20131075. doi: 10.1084\/jem.20042158","journal-title":"J Exp Med"},{"key":"3408_CR29","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1158\/1055-9965.EPI-05-0229","volume":"14","author":"M Butsch Kovacic","year":"2005","unstructured":"Butsch Kovacic M, Martin M, Gao X, Fuksenko T, Chen CJ, Cheng YJ, Chen JY, Apple R, Hildesheim A, Carrington M (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14:2673\u20132677. doi: 10.1158\/1055-9965.epi-05-0229","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3408_CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri750","volume":"2","author":"G Stassi","year":"2002","unstructured":"Stassi G, De Maria R (2002) Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2:195\u2013204. doi: 10.1038\/nri750","journal-title":"Nat Rev Immunol"},{"key":"3408_CR31","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.170.4.2195","volume":"170","author":"RN Dogan","year":"2003","unstructured":"Dogan RN, Vasu C, Holterman MJ, Prabhakar BS (2003) Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves\u2019 disease. J Immunol 170:2195\u20132204","journal-title":"J Immunol"},{"key":"3408_CR32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781\u2013790. doi: 10.1038\/nri1199","journal-title":"Nat Rev Immunol"},{"key":"3408_CR33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1210\/jcem-66-4-702","volume":"66","author":"H Tezuka","year":"1988","unstructured":"Tezuka H, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Ueki Y, Matsunaga M, Shimomura C, Nakao H, Ishikawa N et al (1988) Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves\u2019 disease. J Clin Endocrinol Metab 66:702\u2013707","journal-title":"J Clin Endocrinol Metab"},{"key":"3408_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/08916939209035161","volume":"11","author":"Y Hidaka","year":"1992","unstructured":"Hidaka Y, Amino N, Iwatani Y, Kaneda T, Nasu M, Mitsuda N, Tanizawa O, Miyai K (1992) Increase in peripheral natural killer cell activity in patients with autoimmune thyroid disease. Autoimmunity 11:239\u2013246","journal-title":"Autoimmunity"},{"key":"3408_CR35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1089\/thy.1998.8.1019","volume":"8","author":"BE Wenzel","year":"1998","unstructured":"Wenzel BE, Chow A, Baur R, Schleusener H, Wall JR (1998) Natural killer cell activity in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Thyroid 8:1019\u20131022","journal-title":"Thyroid"},{"key":"3408_CR36","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/eje.1.01906","volume":"152","author":"SB Solerte","year":"2005","unstructured":"Solerte SB, Precerutti S, Gazzaruso C, Locatelli E, Zamboni M, Schifino N, Bonacasa R, Rondanelli M, Taccani D, Ferrari E, Fioravanti M (2005) Defect of a subpopulation of natural killer immune cells in Graves\u2019 disease and Hashimoto\u2019s thyroiditis: normalizing effect of dehydroepiandrosterone sulfate. Eur J Endocrinol 152:703\u2013712. doi: 10.1530\/eje.1.01906","journal-title":"Eur J Endocrinol"},{"key":"3408_CR37","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","volume":"173","author":"GW Nelson","year":"2004","unstructured":"Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173:4273\u20134276","journal-title":"J Immunol"},{"key":"3408_CR38","doi-asserted-by":"crossref","unstructured":"Kulkarni S, Martin MP, Carrington M (2008) The Yin and Yang of HLA and KIR in human disease. In: Mantovani A (ed) Seminars in immunology, vol 6. Elsevier, ScienceDirect, pp 343\u2013352","DOI":"10.1016\/j.smim.2008.06.003"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3408-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-014-3408-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-014-3408-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:16:41Z","timestamp":1559359001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-014-3408-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,23]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["3408"],"URL":"https:\/\/doi.org\/10.1007\/s11033-014-3408-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,23]]}}}